{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:18:51Z","timestamp":1790302731393,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1038\/bjc.2016.3","type":"journal-article","created":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T21:05:25Z","timestamp":1457471125000},"page":"680-687","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia"],"prefix":"10.1038","volume":"114","author":[{"given":"Claudia A","family":"Penafuerte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Gagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinthe","family":"Sirois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel L","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,8]]},"reference":[{"issue":"10","key":"BFbjc20163_CR1","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1016\/j.biocel.2013.07.016","volume":"45","author":"M Amitani","year":"2013","unstructured":"Amitani M, Asakawa A, Amitani H, Inui A (2013) Control of food intake and muscle wasting in cachexia. Int J Biochem Cell Biol 45 (10): 2179\u20132185.","journal-title":"Int J Biochem Cell Biol"},{"issue":"11","key":"BFbjc20163_CR2","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","volume":"14","author":"JM Argiles","year":"2014","unstructured":"Argiles JM, Busquets S, Stemmler B, Lopez-Soriano FJ (2014) Cancer cachexia: understanding the molecular basis. Nat Rev Cancer 14 (11): 754\u2013762.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"BFbjc20163_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s13539-011-0027-5","volume":"2","author":"JM Argiles","year":"2011","unstructured":"Argiles JM, Lopez-Soriano FJ, Toledo M, Betancourt A, Serpe R, Busquets S (2011) The cachexia score (CASCO): a new tool for staging cachectic cancer patients. J Cachexia Sarcopenia Muscle 2 (2): 87\u201393.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"6","key":"BFbjc20163_CR4","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1172\/JCI70522","volume":"124","author":"R Bhadra","year":"2014","unstructured":"Bhadra R, Moretto MM, Castillo JC, Petrovas C, Ferrando-Martinez S, Shokal U, Leal M, Koup RA, Eleftherianos I, Khan IA (2014) Intrinsic TGF-beta signalling promotes age-dependent CD8+T cell polyfunctionality attrition. J Clin Invest 124 (6): 2441\u20132455.","journal-title":"J Clin Invest"},{"issue":"1","key":"BFbjc20163_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bbrc.2014.12.057","volume":"457","author":"E Castillero","year":"2015","unstructured":"Castillero E, Akashi H, Wang C, Najjar M, Ji R, Kennel PJ, Sweeney HL, Schulze PC, George I (2015) Cardiac myostatin upregulation occurs immediately after myocardial ischemia and is involved in skeletal muscle activation of atrophy. Biochem Biophys Res Commun 457 (1): 106\u2013111.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"BFbjc20163_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ijcard.2009.03.006","volume":"144","author":"T Celik","year":"2010","unstructured":"Celik T, Yaman H (2010) Elevated adiponectin levels in patients with chronic heart failure: an independent predictor of mortality or a marker of cardiac cachexia? Int J Cardiol 144 (2): 319\u2013320.","journal-title":"Int J Cardiol"},{"issue":"3","key":"BFbjc20163_CR7","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/01.mco.0000222103.29009.70","volume":"9","author":"P Delafontaine","year":"2006","unstructured":"Delafontaine P, Akao M (2006) Angiotensin II as candidate of cardiac cachexia. Curr Opin Clin Nutr Metab Care 9 (3): 220\u2013224.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"3","key":"BFbjc20163_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/jcp.20099","volume":"201","author":"R DiPietro","year":"2004","unstructured":"DiPietro R, Zauli G (2004) Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand(TRAIL)\/Apo2L. J Cell Physiol 201 (3): 331\u2013340.","journal-title":"J Cell Physiol"},{"issue":"6","key":"BFbjc20163_CR9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ctrv.2013.11.007","volume":"40","author":"E Douglas","year":"2014","unstructured":"Douglas E, McMillan DC (2014) Towards a simple objective framework for the investigation and treatment of cancer cachexia: the Glasgow Prognostic Score. Cancer Treat Rev 40 (6): 685\u2013691.","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"BFbjc20163_CR10","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jaci.2005.02.023","volume":"115","author":"G Fantuzzi","year":"2005","unstructured":"Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115 (5): 911\u2013919, quiz 920.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"BFbjc20163_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12 (5): 489\u2013495.","journal-title":"Lancet Oncol"},{"issue":"2","key":"BFbjc20163_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","volume":"16","author":"KC Fearon","year":"2012","unstructured":"Fearon KC, Glass DJ, Guttridge DC (2012) Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab 16 (2): 153\u2013166.","journal-title":"Cell Metab"},{"issue":"10","key":"BFbjc20163_CR13","first-page":"3059","volume":"119","author":"Z Hu","year":"2009","unstructured":"Hu Z, Wang H, Lee IH, Du J, Mitch WE (2009) Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice. J Clin Invest 119 (10): 3059\u20133069.","journal-title":"J Clin Invest"},{"issue":"7340","key":"BFbjc20163_CR14","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nature09814","volume":"471","author":"F Ikeda","year":"2011","unstructured":"Ikeda F, Deribe YL, Skanland SS, Stieglitz B, Grabbe C, Franz-Wachtel M, vanWijk SJ, Goswami P, Nagy V, Terzic J, Tokunaga F, Androulidaki A, Nakagawa T, Pasparakis M, Iwai K, Sundberg JP, Schaefer L, Rittinger K, Macek B, Dikic I (2011) SHARPIN forms a linear ubiquitin ligase complex regulating NF-kappaB activity and apoptosis. Nature 471 (7340): 637\u2013641.","journal-title":"Nature"},{"issue":"4","key":"BFbjc20163_CR15","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kramer","year":"2014","unstructured":"Kramer A, Green J, PollardJ Jr., Tugendreich S (2014) Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30 (4): 523\u2013530.","journal-title":"Bioinformatics"},{"issue":"18","key":"BFbjc20163_CR16","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.clinbiochem.2007.07.013","volume":"40","author":"M Krzystek-Korpacka","year":"2007","unstructured":"Krzystek-Korpacka M, Matusiewicz M, Diakowska D, Grabowski K, Blachut K, Kustrzeba-Wojcicka I, Banas T (2007) Impact of weight loss on circulating IL-1, IL-6, IL-8, TNF-alpha, VEGF-A, VEGF-C and midkine in gastroesophageal cancer patients. Clin Biochem 40 (18): 1353\u20131360.","journal-title":"Clin Biochem"},{"issue":"19","key":"BFbjc20163_CR17","doi-asserted-by":"publisher","first-page":"5456","DOI":"10.1158\/1078-0432.CCR-13-1066","volume":"19","author":"BJ Laird","year":"2013","unstructured":"Laird BJ, Kaasa S, McMillan DC, Fallon MT, Hjermstad MJ, Fayers P, Klepstad P (2013) Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system. Clin Cancer Res 19 (19): 5456\u20135464.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"BFbjc20163_CR18","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/j.1365-2249.1996.tb08306.x","volume":"103","author":"L Lanza","year":"1996","unstructured":"Lanza L, Scudeletti M, Puppo F, Bosco O, Peirano L, Filaci G, Fecarotta E, Vidali G, Indiveri F (1996) Prednisone increases apoptosis in in vitro activated human peripheral blood T lymphocytes. Clin Exp Immunol 103 (3): 482\u2013490.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"BFbjc20163_CR19","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/MCO.0b013e32833781b5","volume":"13","author":"JJ McCarthy","year":"2010","unstructured":"McCarthy JJ, Esser KA (2010) Anabolic and catabolic pathways regulating skeletal muscle mass. Curr Opin Clin Nutr Metab Care 13 (3): 230\u2013235.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"3","key":"BFbjc20163_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00441-003-0767-4","volume":"313","author":"TJ McLoughlin","year":"2003","unstructured":"McLoughlin TJ, Tsivitse SK, Edwards JA, Aiken BA, Pizza FX (2003) Deferoxamine reduces and nitric oxide synthase inhibition increases neutrophil-mediated myotube injury. Cell Tissue Res 313 (3): 313\u2013319.","journal-title":"Cell Tissue Res"},{"issue":"2","key":"BFbjc20163_CR21","doi-asserted-by":"publisher","first-page":"G147","DOI":"10.1152\/ajpgi.00462.2007","volume":"296","author":"M Moreno","year":"2009","unstructured":"Moreno M, Ramalho LN, Sancho-Bru P, Ruiz-Ortega M, Ramalho F, Abraldes JG, Colmenero J, Dominguez M, Egido J, Arroyo V, Gines P, Bataller R (2009) Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver. Am J Physiol Gastrointest Liver Physiol 296 (2): G147\u2013G156.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"BFbjc20163_CR22","first-page":"1091","volume":"21","author":"AG Moses","year":"2009","unstructured":"Moses AG, Maingay J, Sangster K, Fearon KC, Ross JA (2009) Pro-inflammatory cytokine release by peripheral blood mononuclear cells from patients with advanced pancreatic cancer: relationship to acute phase response and survival. Oncol Rep 21 (4): 1091\u20131095.","journal-title":"Oncol Rep"},{"issue":"5","key":"BFbjc20163_CR23","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1139\/H08-075","volume":"33","author":"M Mourtzakis","year":"2008","unstructured":"Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE (2008) A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 33 (5): 997\u20131006.","journal-title":"Appl Physiol Nutr Metab"},{"issue":"4","key":"BFbjc20163_CR24","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1517\/14728210903369351","volume":"14","author":"KT Murphy","year":"2009","unstructured":"Murphy KT, Lynch GS (2009) Update on emerging drugs for cancer cachexia. Expert Opin Emerg Drugs 14 (4): 619\u2013632.","journal-title":"Expert Opin Emerg Drugs"},{"issue":"4","key":"BFbjc20163_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/SPC.0000000000000091","volume":"8","author":"AA Narsale","year":"2014","unstructured":"Narsale AA, Carson JA (2014) Role of interleukin-6 in cachexia: therapeutic implications. Curr Opin Support Palliat Care 8 (4): 321\u2013327.","journal-title":"Curr Opin Support Palliat Care"},{"issue":"1","key":"BFbjc20163_CR26","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.lungcan.2011.09.012","volume":"76","author":"CM Op den Kamp","year":"2012","unstructured":"Op den Kamp CM, Langen RC, Minnaard R, Kelders MC, Snepvangers FJ, Hesselink MK, Dingemans AC, Schols AM (2012) Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system. Lung Cancer 76 (1): 112\u2013117.","journal-title":"Lung Cancer"},{"issue":"1","key":"BFbjc20163_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1006\/abbi.2001.2687","volume":"397","author":"A Ramaha","year":"2002","unstructured":"Ramaha A, Patston PA (2002) Release and degradation of angiotensin I and angiotensin II from angiotensinogen by neutrophil serine proteinases. Arch Biochem Biophys 397 (1): 77\u201383.","journal-title":"Arch Biochem Biophys"},{"issue":"4","key":"BFbjc20163_CR28","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/sj.bjc.6602725","volume":"93","author":"PM Sanders","year":"2005","unstructured":"Sanders PM, Russell ST, Tisdale MJ (2005) Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role incancer cachexia. Br J Cancer 93 (4): 425\u2013434.","journal-title":"Br J Cancer"},{"issue":"8","key":"BFbjc20163_CR29","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1158\/1078-0432.CCR-12-3027","volume":"19","author":"P Secchiero","year":"2013","unstructured":"Secchiero P, Rimondi E, diIasio MG, Agnoletto C, Melloni E, Volpi I, Zauli G (2013) C-Reactive protein downregulates TRAIL expression in human peripheral monocytes via an Egr-1 dependent pathway. Clin Cancer Res 19 (8): 1949\u20131959.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"BFbjc20163_CR30","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1172\/JCI22324","volume":"115","author":"YH Song","year":"2005","unstructured":"Song YH, Li Y, Du J, Mitch WE, Rosenthal N, Delafontaine P (2005) Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J Clin Invest 115 (2): 451\u2013458.","journal-title":"J Clin Invest"},{"issue":"9","key":"BFbjc20163_CR31","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/nm.2885","volume":"18","author":"S Talukdar","year":"2012","unstructured":"Talukdar S, Oh da Y, Bandyopadhyay G, Li D, Xu J, McNelis J, Lu M, Li P, Yan Q, Zhu Y, Ofrecio J, Lin M, Brenner MB, Olefsky JM (2012) Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med 18 (9): 1407\u20131412.","journal-title":"Nat Med"},{"issue":"4","key":"BFbjc20163_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s13539-011-0043-5","volume":"2","author":"K Trobec","year":"2011","unstructured":"Trobec K, von Haehling S, Anker SD, Lainscak M (2011) Growth hormone, insulin-like growth factor 1, and insulin signaling-a pharmacological target in body wasting and cachexia. J Cachexia Sarcopenia Muscle 2 (4): 191\u2013200.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"BFbjc20163_CR33","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.critrevonc.2013.07.015","volume":"88","author":"A Tuca","year":"2013","unstructured":"Tuca A, Jimenez-Fonseca P, Gascon P (2013) Clinical evaluation and optimal management of cancer cachexia. Crit Rev Oncol Hematol 88 (3): 625\u2013636.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"BFbjc20163_CR34","doi-asserted-by":"publisher","first-page":"F1039","DOI":"10.1152\/ajprenal.00371.2003","volume":"286","author":"DB Vidotti","year":"2004","unstructured":"Vidotti DB, Casarini DE, Cristovam PC, Leite CA, Schor N, Boim MA (2004) High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells. Am J Physiol Renal Physiol 286 (6): F1039\u2013F1045.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"BFbjc20163_CR35","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3892\/etm.2013.909","volume":"5","author":"K Vogiatzi","year":"2013","unstructured":"Vogiatzi K, Apostolakis S, Vlata Z, Krabovitis E, Spandidos DA (2013) Opposite effect of angiotensin receptor blockade on CXCL8 production and CXCR1\/2 expression of angiotensin II treated THP-1monocytes. Exp Ther Med 5 (3): 987\u2013991.","journal-title":"Exp Ther Med"},{"issue":"11","key":"BFbjc20163_CR36","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1038\/sj.ki.5001846","volume":"70","author":"G Wolf","year":"2006","unstructured":"Wolf G (2006) Renal injury due to renin-angiotensin-aldosterone system activation of thet ransforming growth factor-beta pathway. Kidney Int 70 (11): 1914\u20131919.","journal-title":"Kidney Int"},{"issue":"10","key":"BFbjc20163_CR37","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1016\/j.biocel.2013.05.035","volume":"45","author":"T Yoshida","year":"2013","unstructured":"Yoshida T, Tabony AM, Galvez S, Mitch WE, Higashi Y, Sukhanov S, Delafontaine P (2013) Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia. Int J Biochem Cell Biol 45 (10): 2322\u20132332.","journal-title":"Int J Biochem Cell Biol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc20163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc20163","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc20163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:34:03Z","timestamp":1684416843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc20163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["BFbjc20163"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2016.3","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"30 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}